Table 1 Characteristics of the subjects at the baseline
| Â | All subjects | Recovery group | Non-recovery group | P value |
|---|---|---|---|---|
(N = 95) | (N = 36) | (N = 59) | (recovery vs. non-recovery groups) | |
Sex (men/women) | 34/61 | 13/23 | 21/38 | 1.000 |
Age (years) | 84 (61–98) | 81.5 (62–96) | 86 (61–98) | 0.069 |
Number of prescribed medications | 5 (0–16) | 5 (0–14) | 6 (0–16) | 0.401 |
ACBs | 1 (0–6) | 0 (0–6) | 1 (0–4) | 0.654 |
Route of tubal feeding (nasal/gastrostomy) | 62/33 | 26/10 | 36/23 | 0.375 |
Cerebrovascular disease | 71 (74.7%) | 28 (77.8%) | 43 (72.9%) | 0.635 |
Wasting syndrome | 39 (41.1%) | 16 (44.4%) | 23 (39.0%) | 0.669 |
Parkinson’s disease | 10 (10.5%) | 2 (5.6%) | 8 (13.6%) | 0.310 |
Barthel index | ||||
 0–20 | 92 (96.8%) | 34 (94.4%) | 58 (98.3%) | 0.141 |
 21–40 | 1 (1.1%) | 0 (0%) | 1 (1.7%) |  |
  > 40 | 2 (2.1%) | 2 (5.6%) | 0 (0%) |  |
HDS-R | ||||
 0–10 | 84 (88.4%) | 28 (77.8%) | 56 (94.9%) | 0.068 |
 11–20 | 7 (7.4%) | 6 (16.7%) | 1 (1.7%) |  |
  > 20 | 4 (4.2%) | 2 (5.6%) | 2 (3.4%) |  |